期刊文献+

p16及p15基因在子宫颈癌中的纯合性缺失及其临床意义 被引量:1

Homozygous Deletion of p16 and p15 Genes in Cervical Carcinoma and Clinical Significance
下载PDF
导出
摘要 目的 :探讨抑癌基因p16、p15基因的纯合性缺失在子宫颈癌的发生发展中的作用。方法 :应用比较PCR技术检测 34例子宫颈癌组织和 2 0例正常宫颈组织中p16、p15基因的纯合性缺失。结果 :p16、p15基因的纯合性缺失率分别为 11 8%、14 7% ,p16、p15基因的纯合性缺失与组织学类型、临床分期及组织学分级无关。结论 :p16。 Objective:To study the roles of two 2 putative tumor suppressor genes,p16 and p15 genes, in genesis and progression of cervical carcinoma.Methods:Polymerase chain reaction (PCR)based analysis was performed to search for homozygous deletion of the two genes in 34 cervical carcinomas and 20 normal cervical tissues.Results:Homozygous deletion of p16 and p15 genes evaluated by comparative PCR was found in 4 of 34 and 5 of 34 cervical carcinomas respectively while no deletion was detected in corresponding normal tissues. Deletion was not associated with clinical stage and grading.Conclusions:Homozygous deletion of p16 and p15 genes may play an important role in genesis and progression of cervical carcinoma.
出处 《肿瘤防治杂志》 2000年第4期383-385,共3页 China Journal of Cancer Prevention and Treatment
关键词 P16 P15 基因 纯合性缺失 子宫颈癌 p16 p15 gene,homozygous deletion cervical carcinoma
  • 相关文献

参考文献8

  • 1[1]Jen J,Harper JW,Bigner SH.Deletion of p16 and p15 genes in brain tumors[J].Cancer Res 1994,54:6353~6358.
  • 2[2]Kamb A,Gruis N.A,Weaver-Feldhaus J.A cell cycle regulator potentially involved in genesis of many tumor types[J].Science(Washington DC),1994,264:436~440.
  • 3[3]Hortwell L.H,Kastan MB.Cell cycle control and cancer[J].Science,1994,266(5192):1821~1828.
  • 4[4]Serrano M,Hannon GJ,Beach D.A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/cdk4[J].Nature,1993,366(6456):704~707.
  • 5[5]Wong YF,Chung TKH,Cheung TH,et al .p16INK4 and p15INK4B alterations in primary gynecologic malignancy[J].Gynecol Oncol,1997,65:319~324.
  • 6[6]Herman JG,Merlo A,Mao L,et al.Inactivation of the DNKN2/p16/MST lgene is frequently associated with abbrant DNA methylation in all common human cancers [J].Cancer Res,1995,55:4525~4530.
  • 7[7]Wong YF,Chung TK,Cheung TH.Methylation of p16INK4Ain primary gynecologic malignancy[J].Cancer-lett,1999,136(2):231~235.
  • 8[8]Wolf JK,Kim TE.Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus[J].Gynecol Oncol,1999,73(1)27:34~35.

同被引文献1

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部